NEXTBIOMEDICAL receives Japanese regulatory approval for Endoscopin Hemostatic Sytem(Nexpowder™).
The representative of Nextbiomedical stated, “With this PMDA approval, we will strengthen Nexpowder’s presence in the Japanese market—an important player in the medical device industry—by collaborating with Nexpowder’s Japanese distributor, CMI. Through this, we aim to grow into a global medical device company.
